Morning Buzz: KaloBios Pharmaceuticals (KBIO), Netlist Inc. (NLST), Arena Pharmaceuticals (ARNA), Rockwell Medical (RMTI), FireEye (FEYE)

KaloBios Pharmaceuticals, Inc. (KBIO) is one of today’s notable stocks in decline, down as much as 67%. The nosedive comes after the company reported top-line data for Phase 2 Study of KB001-A to treat pseudomonas aeruginosa lung infections in cystic fibrosis patients. KaloBios said that while the data from this study showed KB001-A was generally […] View the full post at: Morning Buzz: KaloBios Pharmaceuticals (KBIO), Netlist Inc. (NLST), Arena Pharmaceuticals (ARNA), Rockwell Medical (RMTI), FireEye (FEYE) No related posts.